Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

Clinical trial NCT06891417 · RECRUITING

Trial details

NCT number: NCT06891417
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chlamydia Trachomatis Immunization

Start date: 2025-03-27
Primary completion: 2028-01-03
Enrollment: 1560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.